Skip to content

Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer Bleeding

Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps in Comparison With Argon Plasma Coagulation for Acute Peptic Ulcer Bleeding

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02020603
Enrollment
151
Registered
2013-12-25
Start date
2012-01-31
Completion date
2014-06-30
Last updated
2016-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Active Peptic Ulcer Disease/GI Bleeding

Keywords

peptic ulcer bleeding, hemostatic forceps, soft coagulation, argon plasma coagulation

Brief summary

Endoscopic high-frequency soft coagulation is available for the management of bleeding or nonbleeding visible vessels during endoscopic submucosal dissection. However, its efficacy on peptic ulcer bleeding has not been elucidated so far. The aim of this study was to evaluate the efficacy of hemostasis with soft coagulation using hemostatic forceps by comparing it with argon plasma coagulation (APC) in a prospective, randomized trial.

Interventions

DEVICEepinephrine injection plus soft coagulation using hemostatic forceps
DEVICEepinephrine injection plus argon plasma coagulation

Sponsors

Kyunghee University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age greater than 18 years * peptic ulcer with stigmata of recent hemorrhage

Exclusion criteria

* malignant ulcer * previous gastric surgery

Design outcomes

Primary

MeasureTime frame
Recurrence of bleeding within four weeks after initial hemostasisup to 24 months

Secondary

MeasureTime frame
initial hemostasis rateup to 24 months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026